SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CYRX

Cryoport, Inc. (NASDAQ:CYRX)

US · Delayed Price · Currency is USD
Industrials · Integrated Freight & Logistics
$19.05-$0.50 (-2.56%)
 
Market cap
$965M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 22, 2005
Market Cap$964.87M+117.0%
Revenue (ttm)$192.44M+1.1%
Net Income-$40.18M-159.5%
EPS-$0.89-176.1%
Shares Out50.65M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume814,779
Open$19.26
Previous Close$19.55
Day's Range$18.81 - $19.30
52-Week Range$7.61 - $21.78
Beta1.89
AnalystsBuy
Price Target$21.93(+15.12%)
Earnings DateMar 2, 2027

About CYRX

Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.

Address
112 Westwood Place, Brentwood, TN, 37027, US
Market Cap
965 million
Employees
688
Industrial Classification
Integrated Freight & Logistics

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$5.80M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
4 Buy0 Hold0 SellAvg target $20.94 (+9.9%)

4 firms rating CYRX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From CYRX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.56%
5 Days
-2.95%
1 Month
+2.81%
6 Months
+33.97%
1 Year
+116.97%

$CYRX stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of CYRX by members of U.S. Congress

Josh GottheimerHouse / DSale$1.00K – $15.00KSep 15, 2023
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KNov 24, 2020
Gilbert CisnerosHouse / DSale$1.00K – $15.00KNov 24, 2020
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KNov 23, 2020
Josh GottheimerHouse / DSale$1.00K – $15.00KNov 13, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KFeb 6, 2020
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KFeb 6, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KFeb 5, 2020

Recently reported changes in CYRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CYRX's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CYRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CYRX Revenue by Segment or Geography

$60.67MTotal
Segment Reporting$50.22M82.78%
Adjusted EBITDA for reportable segments$6.15M10.14%
Investment income$3.03M4.99%
Cost, rent$600.00K0.99%
Cost, stock-based compensation$400.00K0.66%
Engineering and development, stock based compensation$200.00K0.33%
Change in fair value of contingent consideration$72.00K0.12%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CYRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CYRX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CYRX

IWMiShares Russell 2000 ETF$25.58M
VTIVanguard Morningstar Total Stock Market ETF$20.77M
VXFVanguard Extended Market ETF$10.00M
IWNiShares Russell 2000 Value ETF$9.13M
DFASDimensional - US Small Cap ETF$6.00M
SCHASchwab U.S. Small-Cap ETF$5.18M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CYRX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
96
News & Sentiment
20% of score
72

News check: Analyst upgrade with raised price target and positive guidance updates offset valuation concerns and insider selling activity.

Recent Insider Activity

Buys
0
Sells
10
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

NIFEDirexion Fallen Knives ETF1.50%
FESCFirst Eagle Small Cap Equity ETF1.00%
QQQSInvesco NASDAQ Future Gen 200 ETF0.73%
SGRWHarbor Active Small Cap Growth ETF (SGRW)0.70%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.47%
SCDSJPMorgan Fundamental Data Science Small Core ETF0.17%
EESWisdomTree U.S. SmallCap Fund0.15%
VFMOVanguard U.S. Momentum Factor ETF0.11%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.09%
AVSCAvantis U.S. Small Cap Equity ETF0.07%
IWNiShares Russell 2000 Value ETF0.07%
IQESInvesco U.S. Small Cap Enhanced ETF0.06%

Weight is the stock’s share of each fund’s holdings.